Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Proteomic Markers of Intra-amniotic Infection (IAI) in Patients With Preterm Premature Rupture of Amniotic Membranes (PPROM)

NCT00701350 is registered in ClinicalTrials.gov with ProteoGenix, Inc. as lead sponsor.

NCT NCT00701350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Proteomic Markers of Intra-amniotic Infection (IAI) in Patients With Preterm Premature Rupture of Amniotic Membranes (PPROM)
Lead sponsor
ProteoGenix, Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
February 28, 2010
Enrollment
79 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

intra-amniotic infection, preterm birth